Literature DB >> 21543855

Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086).

Laura Cendron1, Daniele Veggi, Enrico Girardi, Giuseppe Zanotti.   

Abstract

fHbp, a highly immunogenic outer membrane protein of Neisseria meningitidis, is responsible for binding to human factor H, a multi-domain protein which is the central regulator of the alternative complement pathway. Here, the crystal structure of mature fHbp determined at 2 Å resolution is presented and is compared with the structure of the same protein in complex with factor H domains 6 and 7 recently solved using X-ray techniques. While the overall protein fold is well conserved, modifications are observed mainly in the loop regions involved in the interaction, reflecting a specific adaptation of fHbp in complexing factor H with high affinity. Such a comparison has to date been impaired by the fact that fHbp models determined by NMR show remarkable differences over the entire structure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543855      PMCID: PMC3087634          DOI: 10.1107/S1744309111006154

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis.

Authors:  Francesca Cantini; Silvana Savino; Maria Scarselli; Vega Masignani; Mariagrazia Pizza; Giacomo Romagnoli; Erwin Swennen; Daniele Veggi; Lucia Banci; Rino Rappuoli
Journal:  J Biol Chem       Date:  2005-12-31       Impact factor: 5.157

3.  Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.

Authors:  Susanne Jacobsson; Sara Thulin; Paula Mölling; Magnus Unemo; Maurizio Comanducci; Rino Rappuoli; Per Olcén
Journal:  Vaccine       Date:  2005-11-16       Impact factor: 3.641

4.  Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

Authors:  Stefania Bambini; Alessandro Muzzi; Per Olcen; Rino Rappuoli; Mariagrazia Pizza; Maurizio Comanducci
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

5.  Structure of the outer membrane protein A transmembrane domain.

Authors:  A Pautsch; G E Schulz
Journal:  Nat Struct Biol       Date:  1998-11

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Authors:  Leah D Fletcher; Liesel Bernfield; Vicki Barniak; John E Farley; Alan Howell; Melissa Knauf; Peggy Ooi; Robert P Smith; Paige Weise; Mike Wetherell; Xiaoling Xie; Robert Zagursky; Ying Zhang; Gary W Zlotnick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.

Authors:  Lisa A Lewis; Jutamas Ngampasutadol; Ruth Wallace; Jane E A Reid; Ulrich Vogel; Sanjay Ram
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

9.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  23 in total

1.  A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.

Authors:  Monica Konar; Rolando Pajon; Peter T Beernink
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

2.  Coarse-grained, foldable, physical model of the polypeptide chain.

Authors:  Promita Chakraborty; Ronald N Zuckermann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

3.  Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.

Authors:  Enrico Malito; Agnese Faleri; Paola Lo Surdo; Daniele Veggi; Giulietta Maruggi; Eva Grassi; Elena Cartocci; Isabella Bertoldi; Alessia Genovese; Laura Santini; Giacomo Romagnoli; Erica Borgogni; Sébastien Brier; Carla Lo Passo; Maria Domina; Flora Castellino; Franco Felici; Stijn van der Veen; Steven Johnson; Susan M Lea; Christoph M Tang; Mariagrazia Pizza; Silvana Savino; Nathalie Norais; Rino Rappuoli; Matthew J Bottomley; Vega Masignani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-08       Impact factor: 11.205

Review 4.  The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.

Authors:  Davide Serruto; Matthew J Bottomley; Sanjay Ram; Marzia M Giuliani; Rino Rappuoli
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

5.  Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.

Authors:  Valentina Rippa; Laura Santini; Paola Lo Surdo; Francesca Cantini; Daniele Veggi; Maria Antonietta Gentile; Eva Grassi; Giulia Iannello; Brunella Brunelli; Francesca Ferlicca; Emiliano Palmieri; Michele Pallaoro; Beatrice Aricò; Lucia Banci; Mariagrazia Pizza; Maria Scarselli
Journal:  Clin Vaccine Immunol       Date:  2015-05-06

6.  Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.

Authors:  Rolando Pajon; Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

7.  Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.

Authors:  Yih-Ling Tzeng; Serena Giuntini; Zachary Berman; Soma Sannigrahi; Dan M Granoff; David S Stephens
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

Review 8.  Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

Authors:  Lisa K McNeil; Robert J Zagursky; Shuo L Lin; Ellen Murphy; Gary W Zlotnick; Susan K Hoiseth; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

9.  Structure of the C-terminal domain of Neisseria heparin binding antigen (NHBA), one of the main antigens of a novel vaccine against Neisseria meningitidis.

Authors:  Veronica Esposito; Valeria Musi; Cesira de Chiara; Daniele Veggi; Davide Serruto; Maria Scarselli; Geoff Kelly; Mariagrazia Pizza; Annalisa Pastore
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

10.  Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein.

Authors:  Peter T Beernink
Journal:  Hum Vaccin Immunother       Date:  2019-10-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.